Antje Belau

Effect of neoadjuvant anthracycline–taxane-based chemotherapy in different biological breast cancer phenotypes: overall results from the GeparTrio study

Jens Huober, Gunter von Minckwitz, Carsten Denkert et al. · Breast Cancer Research and Treatment · 2010 · 289 citations

Tumor Biology, Breast Oncology, Medicine +10

Bevacizumab and platinum-based combinations for recurrent ovarian cancer: a randomised, open-label, phase 3 trial

Jacobus Pfisterer, Catherine Shannon, Klaus Baumann et al. · The Lancet Oncology · 2020 · 157 citations

Medicine, Metronomic Therapy, Gynecology +8

Topotecan Weekly Versus Conventional 5-Day Schedule in Patients With Platinum-Resistant Ovarian Cancer: A Randomized Multicenter Phase II Trial of the North-Eastern German Society of Gynecological Oncology Ovarian Cancer Study Group

Jalid Sehouli, Dirk Stengel, Philipp Harter et al. · Journal of Clinical Oncology · 2010 · 103 citations · Full text

German Adjuvant Intergroup Node-Positive Study: A Phase III Trial to Compare Oral Ibandronate Versus Observation in Patients With High-Risk Early Breast Cancer

Gϋnter von Minckwitz, Volker Möbus, Andreas Schneeweiß et al. · Journal of Clinical Oncology · 2013 · 99 citations

The anti-idiotypic antibody abagovomab in patients with recurrent ovarian cancer. A phase I trial of the AGO-OVAR

Jacobus Pfisterer, Andreas du Bois, Jalid Sehouli et al. · Annals of Oncology · 2006 · 66 citations

Medicine, Gynecology, Recurrent Ovarian Cancer +5